NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCs-Reference-Cited by-同舟云学术

NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCs

Published:2017-09 Issue:3 Volume:9 Page:853-867
ISSN:2213-6711
Container-title:Stem Cell Reports
language:en
Short-container-title:Stem Cell Reports

Author:

Ichise Hiroshi,Nagano Seiji,Maeda Takuya,Miyazaki Masaki,Miyazaki Yuki,Kojima Hiroto,Yawata Nobuyo,Yawata Makoto,Tanaka Hidenori,Saji Hiroh,Masuda Kyoko,Kawamoto Hiroshi

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,Genetics,Biochemistry

Reference41 articles.

1. Efficient cloning and expression of HLAclass I cDNA in human B-lymphoblastoid cell lines;Akatsuka;Tissue Antigens,2002

2. Human NK cell education by inhibitory receptors for MHC class I;Anfossi;Immunity,2006

3. KIR3DL1/HL AB subtypes govern acute myelogenous leukemia relapse after hematopoietic cell transplantation;Boudreau;J. Clin. Oncol.,2017

4. KIR3DL1Allelic polymorphism and HLA-B epitopes modulate response to anti-GD2 monoclonal antibody in patients with neuroblastoma;Forlenza;J. Clin. Oncol.,2016

5. Role of natural-killer group 2 member D ligands and intercellular adhesion molecule 1 in natural killer cell-mediated lysis of murine embryonic stem cells and embryonic stem cell-derived cardiomyocytes;Frenzel;Stem Cells,2009

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppressant therapy averts rejection of allogeneic FKBP1A-disrupted CAR-T cells;Molecular Therapy;2024-09

2. Thymidylate synthase disruption to limit cell proliferation in cell therapies;Molecular Therapy;2024-08

3. Genetically engineered hypoimmunogenic cell therapy;Nature Reviews Bioengineering;2024-07-29

4. Dysregulation of Immune Tolerance to Autologous iPSCs and Their Differentiated Derivatives;Biochemistry (Moscow);2024-05

5. Trends in cell medicine: from autologous cells to allogeneic universal-use cells for adoptive T-cell therapies;International Immunology;2024-01-08